SCHEMBL19233252

SCHEMBL19233252

CC1(C(F)(F)F)CC=CC[C@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3096894 0.72
SCHEMBL11863847 0.72
SCHEMBL23563038 0.67
SCHEMBL14509940 0.65
SCHEMBL14803401 0.60
SCHEMBL14800959 0.60
SCHEMBL25741869 0.59 SLC6A4 (0.31)
SCHEMBL19259352 0.59
SCHEMBL3134312 0.58
SCHEMBL23608547 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017135589-A9 PYRIDINE DERIVATIVE INHIBITING RAF KINASE AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR, METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF 삼진제약주식회사 2017-10-19 WO disclosed
WO-2017135589-A1 PYRIDINE DERIVATIVE INHIBITING RAF KINASE AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR, METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF 삼진제약주식회사 2017-08-10 WO disclosed